Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Pathos AI has launched a $400 million funding round and ...
Pharmaceutical Technology on MSN
Pathos AI raises $365m for oncology drug development
Proceeds from the round will be channelled into progressing the company's clinical-stage pipeline.
CHICAGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Pathos AI, a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, today announced the closing of ...
This UK-based PR firm has a track record of raising the profiles of UK businesses, while helping them stay within reasonable budgets. Pathos Communications presents a unique approach to marketing and ...
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding. The company didn’t disclose the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results